Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3324977 Title: DÉRIVÉS BENZODIAZÉPINE UTILISÉS COMME INHIBITEURS DU VIRUS RESPIRATOIRE SYNCYTIAL (RSV)

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
168285286
WO application number:
US2016043320
Type:
European patent granted for BE
Status:
Open
Publication number:
3324977
WO publication number:
WO2017015449
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/07/2016
Grant date:
13/07/2022
EP publication date:
30/05/2018
WO publication date:
26/01/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
13/07/2022
EP B1 publication date:
13/07/2022
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/07/2036

Applicant

Name:
Enanta Pharmaceuticals, Inc.
Legal Form:
From:
13/07/2022
Address:
500 Arsenal Street, Watertown, MA 02472, United States (US)
To:

Agent

Name:
KEMPES Wouter
Legal Form:
From:
14/09/2022
Address:
P.O. Box 2350, 1200 CJ, HILVERSUM, Netherlands (NL)
To:

Inventor

1

Name:
SHOOK, Brian, C.
Legal Form:
Address:
Holliston, MA 01746, United States (US)

2

Name:
KIM, In, Jong
Legal Form:
Address:
Lexington, MA 02421, United States (US)

3

Name:
BLAISDELL, Thomas, P.
Legal Form:
Address:
Brighton, MA 02135, United States (US)

4

Name:
YU, Jianming
Legal Form:
Address:
Plainsboro, NJ 08536, United States (US)

5

Name:
PANARESE, Joseph
Legal Form:
Address:
Malden, MA 02148, United States (US)

6

Name:
OR, Yat, Sun
Legal Form:
Address:
Watertown, MA 02472, United States (US)

Priority

1

Priority patent number:
201662335227 P
Priority date:
12/05/2016
Priority country:
United States (US)

2

Priority patent number:
201562195648 P
Priority date:
22/07/2015
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07D 243/16; C07D 413/12; C07D 413/14; C07D 417/14; C07D 471/08; C07D 491/048; C07D 495/04; C07D 498/08; C07D 513/04; A61K 45/06; A61K 31/5513; A61K 31/56; A61K 31/58; A61P 11/00; A61P 31/12; A61P 31/16;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2022/13
Publication date:
01/08/2022
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202228
Publication date:
13/07/2022
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/07/2025
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
19/07/2024
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
14/09/2022 Incoming Correspondence (Email) Cover letter 1 PDF /5/3/7/8/3/0722238735/docs/168285286_0_incomingcorrespondenceelectronic_20220915_084550509.pdf
14/09/2022 General Document Other 1 PDF /5/3/7/8/3/0722238735/docs/168285286_1_generaldocument_20220915_084550371.pdf
14/09/2022 Outgoing Correspondence 1 PDF /5/3/7/8/3/0722238735/docs/168285286_2_outgoingcorrespondence_20220915_084550217.pdf